Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Cardiovascular Diseases D002318 24 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Cholecystitis D002764 8 associated lipids
Cholestasis D002779 23 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Cluster Headache D003027 4 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Diseases D003108 5 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Conjunctivitis D003231 7 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Contracture D003286 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Kume K et al. [Study of platelet activating factor by using mouse ontogenic technology]. 1996 Nihon Rinsho Meneki Gakkai Kaishi pmid:9081720
Kioka K et al. [Changes in production of platelet activating factor by adherent hepatocytes of mice with experimental liver failure]. 1989 Nihon Shokakibyo Gakkai Zasshi pmid:2770018
Katoh N et al. [Evaluation of the mechanism of endothelin-induced rat gastric mucosal lesion formation]. 1994 Nihon Shokakibyo Gakkai Zasshi pmid:8309086
Maeda Y [Study of acute gastric mucosal lesion induced by endotoxemia]. 1990 Nihon Shokakibyo Gakkai Zasshi pmid:2214276
Idei H et al. [Role of platelet activating factor on the formation of ischemic colitis]. 1995 Nihon Shokakibyo Gakkai Zasshi pmid:7474465
Nogami M et al. [Effects of a PAF antagonist CV-3988 on the acute gastric erosions of rats by water-immersion stress]. 1988 Nihon Shokakibyo Gakkai Zasshi pmid:3404759
Boku S [A role of platelet activating factor in experimental hemorrhagic enteritis induced by Clostridium difficile toxin]. 1994 Nihon Shokakibyo Gakkai Zasshi pmid:7933638
Iwai A et al. [Role of PAF for the formation of gastric mucosal injury induced by ischemia-reinfusion in the rat]. 1990 Nihon Shokakibyo Gakkai Zasshi pmid:2232300
Nogami M et al. [Effects of a platelet activating factor (PAF) antagonist CV-3988 on acute gastric erosions in rats by water immersion and restrained stress, and by ethanol]. 1988 Nihon Shokakibyo Gakkai Zasshi pmid:3210345
Yoshikawa T et al. [Role of polymorphonuclear leukocytes and oxygen-derived free radicals in the formation of gastric mucosal lesions induced by platelet-activating factor]. 1989 Nihon Shokakibyo Gakkai Zasshi pmid:2547098
Ohtani N and Asano G [Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65]. 1996 Nippon Ika Daigaku Zasshi pmid:8987363
Hasegawa T and Nakajima S [Recent topics on platelet-activating-factor (PAF)]. 1988 Nippon Ika Daigaku Zasshi pmid:3360909
Narita S et al. [Effects of anti-PAF agents on nasal response after allergen challenge in guinea pigs]. 1992 Nippon Jibiinkoka Gakkai Kaiho pmid:1357119
Shirasaki H and Asakura K [Effect of platelet-activating factor on nasal vascular permeability and eosinophil accumulation in guinea pigs]. 1990 Nippon Jibiinkoka Gakkai Kaiho pmid:2376799
Shirasaki H and Asakura K [Detection of platelet-activating factor in nasal lavage fluid from patients with pollinosis and experimental animals with nasal allergy]. 1990 Nippon Jibiinkoka Gakkai Kaiho pmid:2352050
Ozaki Y et al. Potentiation of neutrophil biosynthesis of platelet-activating factor by cytochalasin B: evaluation of acetyltransferase activity. 1987 Nippon Ketsueki Gakkai Zasshi pmid:3687329
Ozaki Y et al. Acetyltransferase activity and production of platelet-activating factor by human neutrophils activated with various stimuli. 1989 Nippon Ketsueki Gakkai Zasshi pmid:2515707
Satoh K and Takamatsu S [Inactivation by plasma of platelet-activating factor]. 1986 Nippon Ketsueki Gakkai Zasshi pmid:3766067
Yamazaki H [Recent medical topics on platelets in hemorrhagic and thrombotic diseases]. 1986 Nippon Naika Gakkai Zasshi pmid:3027214
Itoh M and Takeuchi T [Mechanism of the formation of ischemic gastric injury induced by oxygen radicals in rats]. 1990 Nippon Naika Gakkai Zasshi pmid:2175336
Ogiwara T and Sato N [Stress and etiology of peptic ulcers]. 1995 Nippon Naika Gakkai Zasshi pmid:7658116
Kawatake H and Kawakami Y [Pulmonary thromboembolism and IgE]. 1993 Nippon Naika Gakkai Zasshi pmid:8360566
Yamazaki H [Diagnostic procedure of thrombosis]. 1991 Nippon Naika Gakkai Zasshi pmid:1919199
Yano S [Drug therapy of asthma by antiallergic agents]. 1992 Nippon Naika Gakkai Zasshi pmid:1383362
Nagase T [Respiratory failure]. 2013 Nippon Rinsho pmid:23855209
Shimakura S et al. [Peptic ulcer and arachidonate cascade related compounds]. 1990 Nippon Rinsho pmid:1974655
Ito K [Thrombotic thrombocytopenic purpura--recent development of TTP study]. 1993 Nippon Rinsho pmid:8381882
[General aspects of cytokines]. 1990 Nippon Rinsho pmid:2214199
Deguchi K et al. [Platelet activating factor]. 1987 Nippon Rinsho pmid:3041069
Deguchi K et al. [Blood platelet aggregation]. 1981 Nippon Rinsho pmid:6461781
Kohno S and Nabe T [Inflammatory mediators (leukotrienes, thromboxane A2, tachykinins and others)]. 2001 Nippon Rinsho pmid:11676130
Satoh K et al. [Endothelial injury as an initiating factor: vascular endothelial cell injury and biosynthesis of PAF]. 1988 Nippon Rinsho pmid:3404682
Masugi F et al. [Etiological studies of hypertension. G. APRL (antihypertensive polar renomedullary lipid)]. 1984 Nippon Rinsho pmid:6716685
Sagara H et al. [PAF receptor antagonist in asthma therapy]. 1996 Nippon Rinsho pmid:8950954
Hattori A et al. [Platelets-morphology, shape changing factor, and platelet agglutinating factor. TTP Research Group]. 1993 Nippon Rinsho pmid:8433504
Kuroda M [Eicosanoids and glomerular disease]. 1990 Nippon Rinsho pmid:2384974
Naruse T [Hemolytic uremic syndrome (HUS): pathophysiology--with reference to the differentiation between HUS and thrombotic thrombocytopenic purpura]. 1993 Nippon Rinsho pmid:8433517
Takeda K [Role of increase in permeability and circulatory failure in the development of organ dysfunction in severe acute pancreatitis]. 2004 Nippon Rinsho pmid:15552880
Takase K et al. [New aspects of pharmaco-therapy for acute pancreatitis]. 2004 Nippon Rinsho pmid:15552891
Ushiogi Y et al. [Miscellaneous factors on mechanisms of blood pressure regulation]. 1992 Nippon Rinsho pmid:1635219
Watanabe T [Metabolism and action mechanisms of eicosanoids and platelet-activating factor in the kidney]. 1992 Nippon Rinsho pmid:1337118
Saito H and Tamura Y [Antiatherogenic action of omega-3 polyunsaturated fatty acids]. 1993 Nippon Rinsho pmid:8411664
Kawada I and Takahashi K [A new method for the isolation of peripheral blood eosinophils using flow cytometry (FCM)]. 1993 Nippon Rinsho pmid:8492447
Iwahisa Y et al. [Advance in eosinophil chemotaxis assay method--automatic count of migrated cells by the image analyzing system in the Boyden method]. 1993 Nippon Rinsho pmid:8492448
Fukuda T [The eosinophil and bronchial asthma]. 1993 Nippon Rinsho pmid:8492453
Tsutsui H and Morisawa S [Trend of molecular biological studies on the liver sinusoidal cells--Kupffer cells]. 1993 Nippon Rinsho pmid:8385242
Yanoshita R et al. [Arachidonate cascade and platelet activating factor]. 1990 Nippon Rinsho pmid:2117085
Takizawa H [Eosinophils in immediate allergic reactions]. 1993 Nippon Rinsho pmid:8388063
Tomioka H and Kagami M [Clinical relevance on the inhibition of eosinophil functions--a review with special reference to eosinophilopietic cytokines]. 1993 Nippon Rinsho pmid:8388064
Isogai E et al. [Platelet activating factor (PAF) and Lyme disease]. 1996 Nippon Saikingaku Zasshi pmid:8840817
Fujikami F et al. [Positive and negative effects of progestins on platelet-activating factor acetylhydrolase activity in rat plasma]. 1995 Nippon Sanka Fujinka Gakkai Zasshi pmid:7608617
Takashima M et al. [Effects of estrogen and progestin on platelet-activating factor acetylhydrolase]. 1994 Nippon Sanka Fujinka Gakkai Zasshi pmid:8040619
Okawa T et al. [Endothelin-1-induced contraction of pregnant rat myometrium: role of platelet-activating factor]. 1994 Nippon Sanka Fujinka Gakkai Zasshi pmid:8308402
Kodama H et al. Isolation and identification of embryo-derived platelet-activating factor in mice. 1989 Nippon Sanka Fujinka Gakkai Zasshi pmid:2794622
Kikukawa Y et al. [The role of platelet activating factor in ovulation]. 1990 Nippon Sanka Fujinka Gakkai Zasshi pmid:2401830
Akada S et al. [The role of vitamin E during pregnancy--anti-platelet aggregation activity of alpha-tocopherol]. 1991 Nippon Sanka Fujinka Gakkai Zasshi pmid:2056228
Oh-ishi S [Analysis of chemical mediators involved in acute inflammatory reaction with the rat pleurisy model]. 1997 Nippon Yakurigaku Zasshi pmid:9306414
Kakushi H et al. [Effect of cefaclor on guinea pig platelet aggregation in vitro]. 1990 Nippon Yakurigaku Zasshi pmid:2379885
Takehana Y et al. [Inhibitory effects of OKY-046.HCl, a selective thromboxane (TX) A2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness in guinea pigs]. 1990 Nippon Yakurigaku Zasshi pmid:2303203
Dohi T et al. [Role of platelet-activating factor on spinal pain transduction]. 2006 Nippon Yakurigaku Zasshi pmid:16508219
Morita K et al. [Pain relieving effect of platelet-activating factor (PAF) antagonists in a bone cancer pain model]. 2015 Nippon Yakurigaku Zasshi pmid:26256746
Sasaki Y et al. [Effect of KW-4679, a novel antiallergic drug, on platelet-activating factor (PAF)-induced bronchoconstriction, airway hyperresponsiveness and pulmonary cell accumulation in guinea pigs]. 1995 Nippon Yakurigaku Zasshi pmid:8566911
[Do you know PAF?]. 1980 Nouv Presse Med pmid:7367260
MacIntyre DE et al. Endogenous and pharmacological mechanisms for the regulation of human platelet cytosolic free Ca2+. 1985 Nouv Rev Fr Hematol pmid:2997706
Roussi J et al. [Success of treatment with a low-molecular-weight heparin fraction in a case of pulmonary embolism complicated by heparin-induced thrombopenia]. 1983 Nouv Rev Fr Hematol pmid:6622253
Sasaki T et al. A distribution study of 11C platelet-activating factor (PAF) analogs in normal and tumor-bearing mice. 1996 Nucl. Med. Biol. pmid:8782242
Nimjee SM et al. Translation and Clinical Development of Antithrombotic Aptamers. 2016 Nucleic Acid Ther pmid:26882082
Karantonis HC et al. In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits. 2006 Nutr Metab Cardiovasc Dis pmid:16580585
Erickson KL Dietary fat, breast cancer, and nonspecific immunity. 1998 Nutr. Rev. pmid:9481130
Ohshige A et al. Increased platelet-activating factor-acetylhydrolase activity in the umbilical venous plasma of growth-restricted fetuses. 1999 Obstet Gynecol pmid:9932551
Kobayashi F et al. Platelet-activating factor-acetylhydrolase activity in maternal and umbilical venous plasma obtained from normotensive and hypertensive pregnancies. 1994 Obstet Gynecol pmid:8058231
Hemmings R et al. Platelet-activating factor acetylhydrolase activity in peritoneal fluids of women with endometriosis. 1993 Obstet Gynecol pmid:8423963
Soldi R et al. Platelet-activating factor (PAF) induces the early tyrosine phosphorylation of focal adhesion kinase (p125FAK) in human endothelial cells. 1996 Oncogene pmid:8760293
Denizot Y et al. Tissue concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes' stage of patients. 2003 Oncogene pmid:14562051
Anandi VL et al. Platelet-activating factor promotes motility in breast cancer cells and disrupts non-transformed breast acinar structures. 2016 Oncol. Rep. pmid:26531049
Clinical studies of IL-11, new platelet growth factor, presented. 1997 Oncology (Williston Park, N.Y.) pmid:9057177
Valli A et al. Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways. 2015 Oncotarget pmid:25605240
Sahu RP et al. Radiation therapy generates platelet-activating factor agonists. 2016 Oncotarget pmid:26959112
Cluzel J et al. Inhibition of platelet-activating factor-induced retinal impairments by cholera and pertussis toxins. 1995 Ophthalmic Res. pmid:8538992
Doly M et al. Prevention of chloroquine-induced electroretinographic damage by a new platelet-activating factor antagonist, BN 50730. 1993 Ophthalmic Res. pmid:8259265
Wiebe SH et al. Osteoclast activation in inflammatory periodontal diseases. 1996 Oral Dis pmid:8957930
Goldring WP and Pattenden G Total synthesis of (+/-)-phomactin G, a platelet activating factor antagonist from the marine fungus Phoma sp. 2004 Org. Biomol. Chem. pmid:14770224
Fodran P and Minnaard AJ Catalytic synthesis of enantiopure mixed diacylglycerols – synthesis of a major M. tuberculosis phospholipid and platelet activating factor. 2013 Org. Biomol. Chem. pmid:24191360
Diaper CM et al. A total synthesis of (+/-)-phomactin A. 2003 Org. Biomol. Chem. pmid:14664384
Coy B ED et al. The first diastereoselective synthesis of cinerins A-C, PAF-antagonistic macrophyllin-type bicyclo[3.2.1]octane neolignans, using a novel Pd-catalysed oxyarylation. 2010 Org. Biomol. Chem. pmid:20401372
Mi B and Maleczka RE A Nozaki-Hiyama-Kishi Ni(II)/Cr(II) coupling approach to the phomactins. 2001 Org. Lett. pmid:11388849
Mohr PJ and Halcomb RL Convergent enantioselective synthesis of the tricyclic core of phomactin A. 2002 Org. Lett. pmid:12098260
Houghton TJ et al. Efficient assembly of the phomactin core via two different macrocyclization protocols. 2001 Org. Lett. pmid:11700095
Chemler SR et al. Enantioselective synthesis of the oxadecalin core of phomactin A via a highly stereoselective Diels-Alder reaction. 2001 Org. Lett. pmid:11554815
Toró A et al. Transannular Diels-Alder studies on the asymmetric total synthesis of chatancin: the pyranophane approach. 2000 Org. Lett. pmid:10964353
Cole KP and Hsung RP Intramolecular formal oxa-[3 + 3] cycloaddition approach to the ABD system of phomactin A. 2003 Org. Lett. pmid:14653688
Kallan NC and Halcomb RL Synthesis of the ring system of phomactin D using a Suzuki macrocyclization. 2000 Org. Lett. pmid:10990428
Wang C et al. Total synthesis of (+/-)-paeonilide. 2006 Org. Lett. pmid:16737293
Shi YM et al. Lancolides, antiplatelet aggregation nortriterpenoids with tricyclo[6.3.0.0(2,11)]undecane-bridged system from Schisandra lancifolia. 2013 Org. Lett. pmid:24059675
Tsuji H et al. The presence of platelet-activating factor-acetylhydrolase in human middle ear effusions. 1998 Jan-Feb ORL J. Otorhinolaryngol. Relat. Spec. pmid:9519378
Furukawa M et al. Evidence of platelet-activating factor in nasal polyps. 1992 ORL J. Otorhinolaryngol. Relat. Spec. pmid:1584590
Tatsumi N et al. An anti-platelet activating factor antibody and its effects on platelet aggregation. 1993 Osaka City Med J pmid:8183536
Mizoguchi Y et al. The effect of lipo-prostaglandin E1 on the production of interleukin 1 and platelet-activating factor by hepatic sinusoidal endothelial cells in mice. 1991 Osaka City Med J pmid:1792067
Mizoguchi Y et al. Possible involvement of platelet-activating factor in the induction of liver cell injury. 1990 Osaka City Med J pmid:2074969
Morita K et al. Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice. 2004 Pain pmid:15363879